Top compounds associated with response to CCL23


Feature Type Standardized
Nominal ANOVA
mRNA AC220 GDSC1000 pan-cancer AAC 0.36 7e-27
mRNA linifanib GDSC1000 pan-cancer AAC 0.36 3e-26
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.31 2e-22
mRNA Sorafenib CCLE pan-cancer AAC 0.4 7e-19
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.4 7e-15
mRNA XL-184 GDSC1000 pan-cancer AAC 0.26 2e-14
mRNA ATRA GDSC1000 pan-cancer AAC 0.25 3e-14
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.34 8e-12
mRNA BX-795 GDSC1000 pan-cancer AAC 0.2 5e-09
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.17 7e-08
Download CSV